Original Research

Published on 31 Jan 2024

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

in Thoracic Oncology

Patrizia Ciammella
Salvatore Cozzi
Paolo Borghetti
Marco Galaverni
Valerio Nardone
Maria Paola Ruggieri
Matteo Sepulcri
Vieri Scotti
Alessio Bruni
Francesca Zanelli

Frontiers in Oncology

doi 10.3389/fonc.2024.1325249

1,735 views
1 citation

Original Research

Published on 31 Jan 2024

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

in Thoracic Oncology

Ningning Yan
Huixian Zhang
Sanxing Guo
Ziheng Zhang
Yingchun Xu
Liang Xu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1353491

1,675 views
1 citation

Case Report

Published on 29 Jan 2024

Multiple pulmonary cavernous haemangiomas with concurrent primary pulmonary adenocarcinoma: a case report and literature review

in Thoracic Oncology

Xiao Wang
Tao Ren
Hui You
Wenya Han
Jialong Guo
Meifang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1353592

1,106 views
1 citation

Original Research

Published on 29 Jan 2024

Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1

in Thoracic Oncology

Jinghan Wang
Xiao Tang
Xin Liu
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1243432

989 views
1 citation

Original Research

Published on 26 Jan 2024

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study

in Thoracic Oncology

Akihiro Yoshimura
Takayuki Takeda
Nobutaka Kataoka
Keiko Tanimura
Mototaka Fukui
Yusuke Chihara
Shota Takei
Hayato Kawachi
Kentaro Nakanishi
Yuta Yamanaka

Frontiers in Oncology

doi 10.3389/fonc.2024.1303543

1,381 views

Case Report

Published on 26 Jan 2024

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report

in Thoracic Oncology

Ruiqi Niu
Yiruo Zhang
Jingdan Pang
Qing Zhou
Yu Lei
Yingying Du

Frontiers in Oncology

doi 10.3389/fonc.2024.1341233

1,615 views

Systematic Review

Published on 23 Jan 2024

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

in Thoracic Oncology

Rodrigo Motta-Guerrero
Alejandro Leon Garrido-Lecca
Virgilio E. Failoc-Rojas
Ana Calle-Villavicencio
Robert Villacorta-Carranza
Yesenia Huerta-Collado
Alicia Torres-Mera
Mario J. Valladares-Garrido
Víctor Rivera-Francia
Carlos Carracedo

Frontiers in Oncology

doi 10.3389/fonc.2023.1335373

2,178 views
1 citation

Original Research

Published on 23 Jan 2024

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

in Thoracic Oncology

Anna Valeria Samarelli
Roberto Tonelli
Giulia Raineri
Giulia Bruzzi
Dario Andrisani
Filippo Gozzi
Alessandro Marchioni
Matteo Costantini
Luca Fabbiani
Filippo Genovese

Frontiers in Oncology

doi 10.3389/fonc.2023.1275346

2,882 views
1 citation

Original Research

Published on 23 Jan 2024

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

in Thoracic Oncology

Myriam Mirza
Aseem Shrivastava
Cecile Matthews
Natasha Leighl
Calvin S. H. Ng
David Planchard
Sanjay Popat
Julia Rotow
Egbert F. Smit
Ross Soo

Frontiers in Oncology

doi 10.3389/fonc.2023.1330468

2,669 views

Original Research

Published on 23 Jan 2024

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

in Thoracic Oncology

Magdalena Knetki-Wróblewska
Rafał Dziadziuszko
Tomasz Jankowski
Paweł Krawczyk
Maciej Bryl
Katarzyna Stencel
Anna Wrona
Artur Bandura
Jolanta Smok-Kalwat
Jolanta Rok-Knapińska

Frontiers in Oncology

doi 10.3389/fonc.2024.1341084

2,456 views

Case Report

Published on 23 Jan 2024

Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis

in Thoracic Oncology

Yingshun Yang
Guotian Pei
Mingwei Li
Xiaoxue Ma
Shuai Wang
Xianjun Min
Shushi Meng
Jiayue Qin
Huina Wang
Jun Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1276095

1,084 views

Case Report

Published on 19 Jan 2024

Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy

in Thoracic Oncology

Yaoyao Jing
Xiaoxiao Li
Xiaoyuan Sun
Minghan Ren
Ruoxi Xiao
Jiayu Zhao
Zimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1274034

1,307 views

Clinical Trial

Published on 18 Jan 2024

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

in Thoracic Oncology

Ramón A. Ortiz Carrodeguas
Geidy Lorenzo Monteagudo
Pedro P. Guerra Chaviano
Irene Álvarez Montané
Eva E. Salomón Saldívar
Leonardo Lobaina Lambert
Kirenia Camacho Sosa
Raúl Bermúdez Pino
Poncio Blanco Mustelier
Elba Valdés Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1287902

3,550 views
3 citations

Case Report

Published on 18 Jan 2024

Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report

in Thoracic Oncology

Junzhu Xu
Bo He
Yunan Wang
Mengjia Wu
Yanyi Lu
Zixuan Su
Shujun Liu
Fengmin Yin
Jian-Guo Zhou
Wei Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1268260

2,364 views
1 citation

Original Research

Published on 18 Jan 2024

Prognostic and predictive role of liquid biopsy in lung cancer patients

in Thoracic Oncology

Tuncay Goksel
Su Özgür
Aslı Tetik Vardarlı
Altuğ Koç
Haydar Soydaner Karakuş
Taha Reşid Özdemir
Kadri Murat Erdoğan
Ceyda Aldağ
Ali Veral
Berna Komurcuoglu

Frontiers in Oncology

doi 10.3389/fonc.2023.1275525

1,876 views
3 citations

Systematic Review

Published on 16 Jan 2024

Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Huaiyong Wang
Song Liang
Yue Yu
Yun Han

Frontiers in Oncology

doi 10.3389/fonc.2024.1276549

1,652 views
1 citation

Navigation group

Articles

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

Multiple pulmonary cavernous haemangiomas with concurrent primary pulmonary adenocarcinoma: a case report and literature review

Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis

Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report

Prognostic and predictive role of liquid biopsy in lung cancer patients

Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis